Insmed revenue and financials
$105.23Change from previous close: +1.35%Absolute change: +$1.40
In the fiscal year ended December 2025, Insmed reported revenue of $606.42M (+66.73% year over year). The net loss was $1.28B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +66.73%
- 2025 vs 2024
- Net margin
- -210.5%
- 2024: -251.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -935 | -684 | -536 | -400 | -363 | -219 | -251 | -258 | -160 | -147 |
| Depreciation and amortization | 10.4 | 6.0 | 5.5 | 5.3 | 9.1 | 9.1 | 5.2 | 3.6 | 2.9 | 2.4 |
| Capital expenditure | -32.6 | -21.9 | -13.3 | -9.9 | -7.3 | -6.2 | -42.3 | -13.1 | -3.0 | -4.2 |
| Investing cash flow | -64.6 | -583 | -224 | -34.6 | -64.3 | — | — | — | — | — |
| Financing cash flow | 954 | 1,341 | 168 | 793 | 613 | — | — | — | — | — |
| Debt issued | 0.0 | 150 | 0.0 | 350 | — | — | — | — | — | — |
| Debt repaid | -4.9 | -2.6 | -1.2 | -0.6 | — | — | — | — | — | — |
| Effect of exchange rates | 0.9 | -1.3 | -0.3 | -1.0 | -0.9 | — | — | — | — | — |
| Net change in cash | -44.6 | 72.7 | -592 | 357 | 184 | — | — | — | — | — |
| Free cash flow | -968 | -706 | -550 | -410 | -371 | — | — | — | — | — |
| Levered free cash flow | -564 | -418 | -385 | -200 | -181 | — | — | — | — | — |